Parkinsons Disease Drug Market
1 Study Coverage
1.1 Parkinsons Disease Drug Product Introduction
1.2 Market by Type
1.2.1 Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Market by Application
1.3.1 Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parkinsons Disease Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Parkinsons Disease Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Parkinsons Disease Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Parkinsons Disease Drug Sales by Region
2.4.1 Global Parkinsons Disease Drug Sales by Region (2017-2022)
2.4.2 Global Sales Parkinsons Disease Drug by Region (2023-2028)
2.5 Global Parkinsons Disease Drug Revenue by Region
2.5.1 Global Parkinsons Disease Drug Revenue by Region (2017-2022)
2.5.2 Global Parkinsons Disease Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Parkinsons Disease Drug Sales by Manufacturers
3.1.1 Global Top Parkinsons Disease Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parkinsons Disease Drug in 2021
3.2 Global Parkinsons Disease Drug Revenue by Manufacturers
3.2.1 Global Parkinsons Disease Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Parkinsons Disease Drug Revenue in 2021
3.3 Global Parkinsons Disease Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Parkinsons Disease Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Parkinsons Disease Drug Sales by Type
4.1.1 Global Parkinsons Disease Drug Historical Sales by Type (2017-2022)
4.1.2 Global Parkinsons Disease Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
4.2 Global Parkinsons Disease Drug Revenue by Type
4.2.1 Global Parkinsons Disease Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
4.3 Global Parkinsons Disease Drug Price by Type
4.3.1 Global Parkinsons Disease Drug Price by Type (2017-2022)
4.3.2 Global Parkinsons Disease Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Parkinsons Disease Drug Sales by Application
5.1.1 Global Parkinsons Disease Drug Historical Sales by Application (2017-2022)
5.1.2 Global Parkinsons Disease Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
5.2 Global Parkinsons Disease Drug Revenue by Application
5.2.1 Global Parkinsons Disease Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
5.3 Global Parkinsons Disease Drug Price by Application
5.3.1 Global Parkinsons Disease Drug Price by Application (2017-2022)
5.3.2 Global Parkinsons Disease Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Parkinsons Disease Drug Market Size by Type
6.1.1 North America Parkinsons Disease Drug Sales by Type (2017-2028)
6.1.2 North America Parkinsons Disease Drug Revenue by Type (2017-2028)
6.2 North America Parkinsons Disease Drug Market Size by Application
6.2.1 North America Parkinsons Disease Drug Sales by Application (2017-2028)
6.2.2 North America Parkinsons Disease Drug Revenue by Application (2017-2028)
6.3 North America Parkinsons Disease Drug Market Size by Country
6.3.1 North America Parkinsons Disease Drug Sales by Country (2017-2028)
6.3.2 North America Parkinsons Disease Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Parkinsons Disease Drug Market Size by Type
7.1.1 Europe Parkinsons Disease Drug Sales by Type (2017-2028)
7.1.2 Europe Parkinsons Disease Drug Revenue by Type (2017-2028)
7.2 Europe Parkinsons Disease Drug Market Size by Application
7.2.1 Europe Parkinsons Disease Drug Sales by Application (2017-2028)
7.2.2 Europe Parkinsons Disease Drug Revenue by Application (2017-2028)
7.3 Europe Parkinsons Disease Drug Market Size by Country
7.3.1 Europe Parkinsons Disease Drug Sales by Country (2017-2028)
7.3.2 Europe Parkinsons Disease Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parkinsons Disease Drug Market Size by Type
8.1.1 Asia Pacific Parkinsons Disease Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Parkinsons Disease Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Parkinsons Disease Drug Market Size by Application
8.2.1 Asia Pacific Parkinsons Disease Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Parkinsons Disease Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Parkinsons Disease Drug Market Size by Region
8.3.1 Asia Pacific Parkinsons Disease Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Parkinsons Disease Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Parkinsons Disease Drug Market Size by Type
9.1.1 Latin America Parkinsons Disease Drug Sales by Type (2017-2028)
9.1.2 Latin America Parkinsons Disease Drug Revenue by Type (2017-2028)
9.2 Latin America Parkinsons Disease Drug Market Size by Application
9.2.1 Latin America Parkinsons Disease Drug Sales by Application (2017-2028)
9.2.2 Latin America Parkinsons Disease Drug Revenue by Application (2017-2028)
9.3 Latin America Parkinsons Disease Drug Market Size by Country
9.3.1 Latin America Parkinsons Disease Drug Sales by Country (2017-2028)
9.3.2 Latin America Parkinsons Disease Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Parkinsons Disease Drug Market Size by Type
10.1.1 Middle East and Africa Parkinsons Disease Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Parkinsons Disease Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Parkinsons Disease Drug Market Size by Application
10.2.1 Middle East and Africa Parkinsons Disease Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Parkinsons Disease Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Parkinsons Disease Drug Market Size by Country
10.3.1 Middle East and Africa Parkinsons Disease Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Parkinsons Disease Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis AG Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis AG Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GSK Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 AbbVie
11.4.1 AbbVie Corporation Information
11.4.2 AbbVie Overview
11.4.3 AbbVie Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AbbVie Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AbbVie Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Overview
11.5.3 Merck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Boehringer Ingelheim Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Impax Laboratories
11.7.1 Impax Laboratories Corporation Information
11.7.2 Impax Laboratories Overview
11.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Impax Laboratories Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Impax Laboratories Recent Developments
11.8 Lundbeck
11.8.1 Lundbeck Corporation Information
11.8.2 Lundbeck Overview
11.8.3 Lundbeck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lundbeck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lundbeck Recent Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Corporation Information
11.9.2 Sun Pharma Overview
11.9.3 Sun Pharma Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sun Pharma Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sun Pharma Recent Developments
11.10 Wockhardt
11.10.1 Wockhardt Corporation Information
11.10.2 Wockhardt Overview
11.10.3 Wockhardt Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Wockhardt Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wockhardt Recent Developments
11.11 UCB
11.11.1 UCB Corporation Information
11.11.2 UCB Overview
11.11.3 UCB Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 UCB Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 UCB Recent Developments
11.12 Bausch Health
11.12.1 Bausch Health Corporation Information
11.12.2 Bausch Health Overview
11.12.3 Bausch Health Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Bausch Health Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bausch Health Recent Developments
11.13 Acadia
11.13.1 Acadia Corporation Information
11.13.2 Acadia Overview
11.13.3 Acadia Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Acadia Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Acadia Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Parkinsons Disease Drug Industry Chain Analysis
12.2 Parkinsons Disease Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parkinsons Disease Drug Production Mode & Process
12.4 Parkinsons Disease Drug Sales and Marketing
12.4.1 Parkinsons Disease Drug Sales Channels
12.4.2 Parkinsons Disease Drug Distributors
12.5 Parkinsons Disease Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Parkinsons Disease Drug Industry Trends
13.2 Parkinsons Disease Drug Market Drivers
13.3 Parkinsons Disease Drug Market Challenges
13.4 Parkinsons Disease Drug Market Restraints
14 Key Findings in The Global Parkinsons Disease Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Carbidopa/Levodopa
Table 3. Major Manufacturers of Dopamine Receptor Agonists
Table 4. Major Manufacturers of MAO-Inhibitors
Table 5. Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Parkinsons Disease Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 8. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
Table 9. Global Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 10. Global Parkinsons Disease Drug Sales Market Share by Region (2023-2028)
Table 11. Global Parkinsons Disease Drug Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Parkinsons Disease Drug Revenue Market Share by Region (2017-2022)
Table 13. Global Parkinsons Disease Drug Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Parkinsons Disease Drug Revenue Market Share by Region (2023-2028)
Table 15. Global Parkinsons Disease Drug Sales by Manufacturers (2017-2022) & (K Doses)
Table 16. Global Parkinsons Disease Drug Sales Share by Manufacturers (2017-2022)
Table 17. Global Parkinsons Disease Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Parkinsons Disease Drug Revenue Share by Manufacturers (2017-2022)
Table 19. Parkinsons Disease Drug Price by Manufacturers (2017-2022) &(USD/Dose)
Table 20. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Parkinsons Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2021)
Table 22. Parkinsons Disease Drug Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Parkinsons Disease Drug Product Offered
Table 24. Date of Manufacturers Enter into Parkinsons Disease Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 27. Global Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 28. Global Parkinsons Disease Drug Sales Share by Type (2017-2022)
Table 29. Global Parkinsons Disease Drug Sales Share by Type (2023-2028)
Table 30. Global Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Parkinsons Disease Drug Revenue Share by Type (2017-2022)
Table 33. Global Parkinsons Disease Drug Revenue Share by Type (2023-2028)
Table 34. Parkinsons Disease Drug Price by Type (2017-2022) & (USD/Dose)
Table 35. Global Parkinsons Disease Drug Price Forecast by Type (2023-2028) & (USD/Dose)
Table 36. Global Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 37. Global Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 38. Global Parkinsons Disease Drug Sales Share by Application (2017-2022)
Table 39. Global Parkinsons Disease Drug Sales Share by Application (2023-2028)
Table 40. Global Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Parkinsons Disease Drug Revenue Share by Application (2017-2022)
Table 43. Global Parkinsons Disease Drug Revenue Share by Application (2023-2028)
Table 44. Parkinsons Disease Drug Price by Application (2017-2022) & (USD/Dose)
Table 45. Global Parkinsons Disease Drug Price Forecast by Application (2023-2028) & (USD/Dose)
Table 46. North America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 47. North America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 48. North America Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 51. North America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 52. North America Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 55. North America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 56. North America Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 59. Europe Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 60. Europe Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 63. Europe Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 64. Europe Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 67. Europe Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 68. Europe Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 71. Asia Pacific Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 72. Asia Pacific Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 75. Asia Pacific Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 76. Asia Pacific Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 79. Asia Pacific Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 80. Asia Pacific Parkinsons Disease Drug Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Parkinsons Disease Drug Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 83. Latin America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 84. Latin America Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 87. Latin America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 88. Latin America Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 91. Latin America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 92. Latin America Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 95. Middle East and Africa Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 96. Middle East and Africa Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 99. Middle East and Africa Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 100. Middle East and Africa Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 103. Middle East and Africa Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 104. Middle East and Africa Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 106. Teva Corporation Information
Table 107. Teva Description and Major Businesses
Table 108. Teva Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 109. Teva Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Teva Recent Developments
Table 111. Novartis AG Corporation Information
Table 112. Novartis AG Description and Major Businesses
Table 113. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 114. Novartis AG Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Novartis AG Recent Developments
Table 116. GSK Corporation Information
Table 117. GSK Description and Major Businesses
Table 118. GSK Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 119. GSK Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. GSK Recent Developments
Table 121. AbbVie Corporation Information
Table 122. AbbVie Description and Major Businesses
Table 123. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 124. AbbVie Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. AbbVie Recent Developments
Table 126. Merck Corporation Information
Table 127. Merck Description and Major Businesses
Table 128. Merck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 129. Merck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Merck Recent Developments
Table 131. Boehringer Ingelheim Corporation Information
Table 132. Boehringer Ingelheim Description and Major Businesses
Table 133. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 134. Boehringer Ingelheim Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Boehringer Ingelheim Recent Developments
Table 136. Impax Laboratories Corporation Information
Table 137. Impax Laboratories Description and Major Businesses
Table 138. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 139. Impax Laboratories Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Impax Laboratories Recent Developments
Table 141. Lundbeck Corporation Information
Table 142. Lundbeck Description and Major Businesses
Table 143. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 144. Lundbeck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Lundbeck Recent Developments
Table 146. Sun Pharma Corporation Information
Table 147. Sun Pharma Description and Major Businesses
Table 148. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 149. Sun Pharma Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Sun Pharma Recent Developments
Table 151. Wockhardt Corporation Information
Table 152. Wockhardt Description and Major Businesses
Table 153. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 154. Wockhardt Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Wockhardt Recent Developments
Table 156. UCB Corporation Information
Table 157. UCB Description and Major Businesses
Table 158. UCB Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 159. UCB Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. UCB Recent Developments
Table 161. Bausch Health Corporation Information
Table 162. Bausch Health Description and Major Businesses
Table 163. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 164. Bausch Health Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Bausch Health Recent Developments
Table 166. Acadia Corporation Information
Table 167. Acadia Description and Major Businesses
Table 168. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 169. Acadia Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Acadia Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Parkinsons Disease Drug Distributors List
Table 174. Parkinsons Disease Drug Customers List
Table 175. Parkinsons Disease Drug Market Trends
Table 176. Parkinsons Disease Drug Market Drivers
Table 177. Parkinsons Disease Drug Market Challenges
Table 178. Parkinsons Disease Drug Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinsons Disease Drug Product Picture
Figure 3. Global Parkinsons Disease Drug Market Share by Type in 2021 & 2028
Figure 3. Carbidopa/Levodopa Product Picture
Figure 4. Dopamine Receptor Agonists Product Picture
Figure 5. MAO-Inhibitors Product Picture
Figure 6. Global Parkinsons Disease Drug Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinics
Figure 9. Other
Figure 10. Parkinsons Disease Drug Report Years Considered
Figure 11. Global Parkinsons Disease Drug Sales 2017-2028 (K Doses)
Figure 12. Global Parkinsons Disease Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Parkinsons Disease Drug Revenue 2017-2028 (US$ Million)
Figure 14. Global Parkinsons Disease Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
Figure 16. Global Parkinsons Disease Drug Sales Market Share by Region (2023-2028)
Figure 17. North America Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 18. North America Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 20. Europe Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 22. Asia-Pacific Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 24. Latin America Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
Figure 26. Middle East & Africa Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Parkinsons Disease Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Parkinsons Disease Drug in the World: Market Share by Parkinsons Disease Drug Revenue in 2021
Figure 29. Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 31. Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
Figure 32. Global Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 33. Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
Figure 34. North America Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 35. North America Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
Figure 36. North America Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 37. North America Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
Figure 38. North America Parkinsons Disease Drug Sales Share by Country (2017-2028)
Figure 39. North America Parkinsons Disease Drug Revenue Share by Country (2017-2028)
Figure 40. U.S. Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 43. Europe Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
Figure 44. Europe Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 45. Europe Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
Figure 46. Europe Parkinsons Disease Drug Sales Share by Country (2017-2028)
Figure 47. Europe Parkinsons Disease Drug Revenue Share by Country (2017-2028)
Figure 48. Germany Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 49. France Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Parkinsons Disease Drug Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Parkinsons Disease Drug Revenue Share by Region (2017-2028)
Figure 59. China Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 62. India Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 70. Latin America Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 72. Latin America Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Parkinsons Disease Drug Sales Share by Country (2017-2028)
Figure 74. Latin America Parkinsons Disease Drug Revenue Share by Country (2017-2028)
Figure 75. Mexico Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Parkinsons Disease Drug Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Parkinsons Disease Drug Revenue Share by Country (2017-2028)
Figure 84. Turkey Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
Figure 87. Parkinsons Disease Drug Value Chain
Figure 88. Parkinsons Disease Drug Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Industry Market Size
